Redefi ning the irreducible minimum -a long journey in a short time Editorial early ten years ago, the National Audit Offi ce ( NAO, 2000 ) reported that infection control professionals believed that between 5 % and 20 % of healthcare associated infections were preventable. If one were to turn this around there was therefore an assumption that from 80 % to 95 % of infections were inevitable. Within ten years of the publication of this report these assumptions have been proved to be an unduly pessimistic assessment.
The health services across most of the British Isles continue to report signifi cant reductions in healthcare associated infections caused by meticillin resistant Staphylococcus aureus (MRSA) and Clostridium diffi cile. Rates have been falling for approximately two years now and continue to confound the expectations of those who thought reductions of the magnitude now being seen in England and elsewhere were impossible. Death rates have also begun to fall for the fi rst time according to recent fi gures from England ( Offi ce of National Statistics 1 and 2, 2009a , b ) with a 23 % reduction in the recording of MRSA as a cause of death and a greater reduction of 29% in citations of C. diffi cile on death certifi cates. Surely then this is a cause for celebration?
It is possible to suggest that the setting of a highly challenging target of a 50 % reduction in bloodstream infections caused by MRSA within three years by Dr John Reid when Minister for Health in 2003 was the single most effective measure that led to reductions in infections in the NHS in England. This measure brought with it the scrutiny that meant that organisations really began to focus on infection prevention as an integral part of the strategy and focus of the organisation. Rarely can the actions of a politician have had such a direct effect on outcomes of health care for many thousands of patients. Let us not forget that many professionals in the fi eld, myself included, thought that reductions of this magnitude were impossible in the timescale.
Having seen infections decrease so dramatically, what lessons can be learned from the past few years. Can we realistically state with any confi dence how these reductions have been made? Determining the key interventions that have led to the decline in MRSA bacteraemia particularly, and to an increasing extent how reductions in C. diffi cile have come about, will sadly be impossible. Although root cause analyses have demonstrated areas for improvement and action at local level the information has not been collated nationally and an opportunity has been missed.
Although this is disappointing, it is possible to view the large number of MRSA bacteraemia cases as an outbreak that has encompassed every nation. When in an outbreak situation multiple measures are taken in order to regain control. It is signifi cant that in England for a while after the targets were set the fi gures did not improve, then slowly they began to fall with reductions gathering apace. Practice improvement can take a little time to achieve, especially where staff have long-held beliefs that some infection is inevitable.
Part of this problem historically has been the lack of hard science to back up the potential for improvement. Provision of local data that focuses minds has also been variable. The introduction of bundles of care, where a number of evidence-based measures are introduced and performance in implementing all of the interventions is fed back to clinical teams, has been important. The benefi ts of the care bundles that lead to consistency of practice are two-fold. They ensure delivery of reliable and measurable standards of clinical practice that demonstrably reduce infection and additionally provide assurance of consistent performance that will remove variations in clinical practice that make it diffi cult to evaluate the effects of new measures, practices or technologies.
Where should attention now be focused? Reducing infections relating to two organisms has been criticised as having too narrow a focus; however this does not mean that the choice was inappropriate as clearly there were problems in those areas. There are many other healthcare acquired infections that have remained largely unaffected by the programmes to date and the implementation of surveillance systems that provide information back to staff teams will serve to identify further areas for action. Challenges in this area clearly remain, especially with the identifi cation of infections outside hospital settings where surveillance systems are often rudimentary.
Should we then, celebrate reducing infections? Unsurprisingly, the reductions in infection are poorly covered in media that were only too happy to place increases at the forefront of news reporting. Announcements of further reductions and falling death rates are mentioned (if at all) in passing, sadly missing the opportunity of restoring public confi dence that the media helped to erode. Pressure groups have been more supportive, recognising improvement while continuing their important campaigns for safer care for patients.
Many professionals in the fi eld of infection prevention and control have felt that although most welcome, the reductions have been made possible by a historic lack of organisational focus on patient safety leading to the rise of infections that created such an opportunity to improve. For many, it has taken many years of perseverance and endeavour to become an overnight success. Yet a success story it is and looking forward, one that leads to a time of opportunity for further and sustainable reductions in preventable infections.
The most important recognition of success however has come from staff at the front line who now have a new and growing confi dence that infections can be prevented; a confi dence that was previously absent. The acceptance of infection as an unfortunate consequence of highly technical health care in an ageing population is being replaced with a growing sense of personal responsibility for practice. This sense of accountability and recognition that they can make a difference will serve to protect the increasingly vulnerable users of healthcare provision.
An increasing body of published evidence of the successful implementation of measures that have demonstrably reduced infection should bolster confi dence that a difference can be made still further. Where infection prevention and control professionals may not celebrate reductions in infections, we must allow and encourage the staff teams who are making improvements at the point of care and are seeing reductions in infection to do so. Celebrating success is highly motivational. A successful staff team is a highly motivated team and this will lead to increased confi dence that more can be done and a willingness to explore every opportunity to further reduce risks for patients. It would be interesting to obtain another opinion from professionals working in infection prevention and control as to the potential for preventability. I suspect that the previous fi gure of 5-20% would be reversed to closer to the 80-95 % previously thought to be unpreventable. How much have we moved in such a relatively short time.
